Altered Expression of EPO Might Underlie Hepatic Hemangiomas in LRRK2 Knockout Mice
Parkinson’s disease (PD) is a severe neurodegenerative disorder caused by progressive loss of dopaminergic neurons in the substantia nigra pars compacta of the midbrain. The molecular mechanism of PD pathogenesis is unclear. Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are a common gen...
Main Authors: | Ben Wu, Kaifu Xiao, Zhuohua Zhang, Long Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2016/7681259 |
Similar Items
-
<it>LRRK2</it> knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors
by: Hinkle Kelly M, et al.
Published: (2012-05-01) -
Cholesterol-Induced Hepatic Inflammation Does Not Underlie the Predisposition to Insulin Resistance in Dyslipidemic Female LDL Receptor Knockout Mice
by: Nanda Gruben, et al.
Published: (2015-01-01) -
Expression analysis of Lrrk1, Lrrk2 and Lrrk2 splice variants in mice.
by: Florian Giesert, et al.
Published: (2013-01-01) -
Erythropoietin in COVID-19-Induced Neuroinflammation; EPO Plus Losartan Might be Promising
by: Reza Nejat, et al.
Published: (2020-12-01) -
Unaltered striatal dopamine release levels in young Parkin knockout, Pink1 knockout, DJ-1 knockout and LRRK2 R1441G transgenic mice.
by: Gonzalo Sanchez, et al.
Published: (2014-01-01)